ID   NZOV13
AC   CVCL_LJ77
SY   NZOV-13; New Zealand OVarian line 13
DR   Wikidata; Q54931647
RX   PubMed=7718330;
RX   PubMed=19493612;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
RX   PubMed=19493612; DOI=10.1016/j.canlet.2009.05.010;
RA   Ramachandran, Anassuya
RA   Marshall, Elaine S.
RA   Love, Donald R.
RA   Baguley, Bruce Charles
RA   Shelling, Andrew N.
RT   "Activin is a potent growth suppressor of epithelial ovarian cancer
RT   cells.";
RL   Cancer Lett. 285:157-165(2009).
//
RX   PubMed=7718330; DOI=10.1016/0959-8049(94)00472-H;
RA   Baguley, Bruce Charles
RA   Marshall, Elaine S.
RA   Whittaker, John Richard
RA   Dotchin, M.C.
RA   Nixon, Johanna
RA   McCrystal, Michael R.
RA   Finlay, Graeme John
RA   Matthews, John H.L.
RA   Holdaway, Karen M.
RA   van Zijl, Pierre Leonardus
RT   "Resistance mechanisms determining the in vitro sensitivity to
RT   paclitaxel of tumour cells cultured from patients with ovarian
RT   cancer.";
RL   Eur. J. Cancer 31A:230-237(1995).
//